Integrated Wealth Concepts’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-16,558
| Closed | -$712K | – | 1843 |
|
|
2024
Q4 | $712K | Buy |
16,558
+168
| +1% | +$7.22K | 0.01% | 969 |
|
|
2024
Q3 | $727K | Sell |
16,390
-1,185
| -7% | -$52.6K | 0.01% | 931 |
|
|
2024
Q2 | $699K | Buy |
17,575
+973
| +6% | +$38.7K | 0.01% | 907 |
|
|
2024
Q1 | $716K | Buy |
16,602
+2,169
| +15% | +$93.6K | 0.01% | 893 |
|
|
2023
Q4 | $601K | Buy |
14,433
+2,079
| +17% | +$86.5K | 0.01% | 916 |
|
|
2023
Q3 | $491K | Buy |
12,354
+65
| +0.5% | +$2.58K | 0.01% | 987 |
|
|
2023
Q2 | $504K | Buy |
12,289
+19
| +0.2% | +$779 | 0.01% | 979 |
|
|
2023
Q1 | $503K | Hold |
12,270
| – | – | 0.01% | 854 |
|
|
2022
Q4 | $502K | Sell |
12,270
-168
| -1% | -$6.87K | 0.01% | 658 |
|
|
2022
Q3 | $500K | Buy |
12,438
+279
| +2% | +$11.2K | 0.02% | 593 |
|
|
2022
Q2 | $511K | Buy |
12,159
+1,303
| +12% | +$54.8K | 0.02% | 597 |
|
|
2022
Q1 | $491K | Buy |
10,856
+2,618
| +32% | +$118K | 0.02% | 578 |
|
|
2021
Q4 | $380K | Buy |
8,238
+1,354
| +20% | +$62.5K | 0.01% | 685 |
|
|
2021
Q3 | $327K | Buy |
+6,884
| New | +$327K | 0.01% | 708 |
|